|
WO2021068910A1
|
|
Target for screening anti-tumor drug, use thereof and screening method therefor
|
|
WO2020228477A1
|
|
Drug and combination product used for prevention, alleviation and/or treatment of fibrosis, and use thereof
|
|
CN111671762A
|
|
Application of acylated spiramycin in preparing medicine for treating coronavirus infection disease
|
|
CN112239483A
|
|
Novel compound and pharmaceutical composition
|
|
WO2019201268A1
|
|
Drug used for preventing and/or treating pain and/or fever, combination product, and use thereof
|
|
CN110384710A
|
|
It is a kind of for preventing and/or treating the drug, combination product and its application of pain
|
|
CN110384802A
|
|
It is a kind of for preventing and/or treating the drug, combination product and its application of fever
|
|
CN110051678A
|
|
A kind of drug and purposes prevented and/or treat diabetes
|
|
CN110051679A
|
|
A kind of composition and application thereof to delay senescence and/or extend the service life
|
|
CA3088818A1
|
|
Mtor inhibitor, pharmaceutical composition and use thereof
|
|
KR20200112898A
|
|
Use of caramycin or its active ingredient
|
|
CN110051680A
|
|
It is a kind of for preventing and/or treating the drug, combination product and its application of Alzheimer disease
|
|
CN111349595A
|
|
Spiramycin-producing strain, rokitamycin-producing strain, construction method, application and method for improving product yield
|
|
CA3068921A1
|
|
Use of isovaleryl spiramycin i, ii and/or iii in manufacturing medicament for treating and/or preventing tumor and medicament
|
|
CN110545820A
|
|
Application of kelimycin and pharmaceutically acceptable salt thereof in preparing medicaments for treating and/or preventing tumors
|
|
CN107868789A
|
|
Rokitamycin biological synthesis gene cluster
|
|
EP3210990A1
|
|
Levoisovalerylspiramycin iii and preparations, preparation methods and uses thereof
|
